Structural requirements of human ether-a-go-go-related gene channels for block by bupivacaine

Anesthesiology

Volumn 106, Issue 3, 2007, Pages 523-531

  Siebrands, Cornelia C ^a   Friederich, Patrick ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; BUPIVACAINE; POTASSIUM CHANNEL HERG; THREONINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG MECHANISM; ELECTROPHYSIOLOGY; FEMALE; GENE STRUCTURE; IC 50; INHIBITION KINETICS; NONHUMAN; OOCYTE; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VOLTAGE CLAMP; WILD TYPE; XENOPUS LAEVIS;

AMINO ACID SUBSTITUTION; ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; ELECTROPHYSIOLOGY; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; MUTAGENESIS, SITE-DIRECTED; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS; XENOPUS LAEVIS;

EID: 34247473376     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200703000-00017     Document Type: Article

References (27)

1. Kasten GW: Amide local anesthetic alterations of effective refractory period temporal dispersion: Relationship to ventricular arrhythmias. ANESTHESIOLOGY 1986; 65:61-6
2. Albright GA: Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. ANESTHESIOLOGY 1979; 51:285-7
3. Polley LS, Santos AC: Cardiac arrest following regional anesthesia with ropivacaine: Here we go again! ANESTHESIOLOGY 2003; 99:1253-4
4. Mitcheson JS, Chen J, Sanguinetti MC: Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate. J Gen Physiol 2000; 115:229-40
5. Lipka LJ, Jiang M, Tseng GN: Differential effects of bupivacaine on cardiac K channels: role of channel inactivation and subunit composition in drug-channel interaction. J Cardiovasc Electrophysiol 1998; 9:727-42
6. Gonzalez T, Arias C, Caballero R, Moreno I, Delpon E, Tamargo J, Valenzuela C: Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: Stereoselective bupivacaine block. Br J Pharmacol 2002; 137:1269-79
7. Friederich P, Solth A, Schillemeit S, Isbrandt D: Local anaesthetic sensitivities of cloned HERG channels from human heart: Comparison with HERG/MiRP1 and HERG/MiRP1 T8A. Br J Anaesth 2004; 92:93-101
8. Siebrands CC, Schmitt N, Friederich P: Local anesthetic interaction with human ether-a-go-go-related gene (HERG) channels: Role of aromatic amino acids Y652 and F656. ANESTHESIOLOGY 2005; 103:102-12
9. Sanguinetti MC, Jiang C, Curran ME, Keating MT: A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995; 81:299-307
10. Sanguinetti MC, Tristani-Firouzi M: hERG potassium channels and cardiac arrhythmia. Nature 2006; 440:463
11. del Camino D, Holmgren M, Liu Y, Yellen G: Blocker protection in the pore of a voltage-gated K+ channel and its structural implications. Nature 2000; 403:321-5
12. Mitcheson JS, Chen J, Lin M, Culberson C, Sanguinetti MC: A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci U S A 2000; 97:12329-33
13. Kamiya K, Mitcheson JS, Yasui K, Kodama I, Sanguinetti MC: Open channel block of HERG K(+) channels by vesnarinone. Mol Pharmacol 2001; 60: 244-53
14. Perry M, de Groot MJ, Helliwell R, Leishman D, Tristani-Firouzi M, Sanguinetti MC, Mitcheson J: Structural determinants of HERG channel block by clofilium and ibutilide. Mol Pharmacol 2004; 66:240-9
15. Kamiya K, Niwa R, Mitcheson JS, Sanguinetti MC: Molecular determinants of HERG channel block. Mol Pharmacol 2006; 69:1709-16
16. Mitcheson JS: Drug binding to HERG channels: Evidence for a "non-aromatic" binding site for fluvoxamine. Br J Pharmacol 2003; 139:883-4
17. Higuchi R, Krummel B, Saiki RK: A general method of in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interactions. Nucleic Acids Res 1988; 16:7351-67
18. Smith PL, Baukrowitz T, Yellen G: The inward rectification mechanism of the HERG cardiac potassium channel. Nature 1996; 379:833-6
19. Wang S, Morales MJ, Liu S, Strauss HC, Rasmusson RL: Modulation of HERG affinity for E-4031 by [K+]o and C-type inactivation. FEBS Lett 1997; 417:43-7
20. Yang T, Roden DM: Extracellular potassium modulation of drug block of IKr: Implications for torsade de pointes and reverse use-dependence. Circulation 1996; 93:407-11
21. Ficker E, Jarolimek W, Kiehn J, Baumann A, Brown AM: Molecular determinants of dofetilide block of HERG K+ channels. Circ Res 1998; 82:386-95
22. Lin J, Guo J, Gang H, Wojciechowski P, Wigle JT, Zhang S: Intracellular K+ is required for the inactivation-induced high-affinity binding of cisapride to HERG channels. Mol Pharmacol 2005; 68:855-65
23. Witchel HJ, Dempsey CE, Sessions RB, Perry M, Milnes JT, Hancox JC, Mitcheson JS: The low-potency, voltage-dependent HERG blocker propafenone: Molecular determinants and drug trapping. Mol Pharmacol 2004; 66:1201-12
24. Guo J, Gang H, Zhang S: Molecular determinants of cocaine block of human ether-a-go-go-related gene potassium channels. J Pharmacol Exp Ther 2006; 317:865-74
25. Perry M, Stansfeld PJ, Leaney J, Wood C, de Groot MJ, Leishman D, Sutcliffe MJ, Mitcheson JS: Drug binding interactions in the inner cavity of HERG channels: Molecular insights from structure-activity relationships of clofilium and ibutilide analogs. Mol Pharmacol 2006; 69:509-19
26. Sanchez-Chapula JA, Ferrer T, Navarro-Polanco RA, Sanguinetti MC: Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain. Mol Pharmacol 2003; 63:1051-8
27. Sanchez-Chapula JA, Navarro-Polanco RA, Culberson C, Chen J, Sanguinetti MC: Molecular determinants of voltage-dependent human ether-a-go-go related gene (HERG) K+ channel block. J Biol Chem 2002; 277:23587-95